Page last updated: 2024-10-31

metoprolol and Experimental Lung Inflammation

metoprolol has been researched along with Experimental Lung Inflammation in 2 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yang, F1
Yu, J1
Dong, W1
Han, W1
Qiao, C1
Wang, Y1
Sibal, L1
Jovanovic, A1
Agarwal, SC1
Peaston, RT1
James, RA1
Lennard, TW1
Bliss, R1
Batchelor, A1
Perros, P1

Other Studies

2 other studies available for metoprolol and Experimental Lung Inflammation

ArticleYear
Efficacy observation and analysis of metoprolol combined with dopamine in patients with severe pneumonia complicated with heart failure.
    Panminerva medica, 2022, Volume: 64, Issue:3

    Topics: Adrenergic beta-Antagonists; Dopamine; Heart Failure; Humans; Metoprolol; Pneumonia

2022
Phaeochromocytomas presenting as acute crises after beta blockade therapy.
    Clinical endocrinology, 2006, Volume: 65, Issue:2

    Topics: Acute Disease; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic beta-Antagonists; Adult; Cardiomyo

2006